SPHK2 and neoplasm: We recently reported that targeting SphK2 using either RNA interference or a selective small-molecule inhibitor, ABC294640, induces caspase-mediated apoptosis for KSHV-infected PEL cells and suppresses PEL tumor progression in vivo [19].